Topotecan Hydrochloride Injection, Powder, Lyophilized, For Solution
Product Images NDC 45963-615

3 FDA label images from Actavis Pharma, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Topotecan Hydrochloride (NDC 45963-615). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

1 (Image 1)

1 (Image 1)
Chemical structure of Topotecan hydrochloride, showing its molecular framework including hydroxyl groups, nitrogen atoms, methyl group, and hydrochloride salt.*
FDA Label Image

` (Image 2)

` (Image 2)
A Kaplan-Meier survival curve comparing Proportion Surviving over Months on Study between Topotecan hydrochloride plus Cisplatin and Cisplatin Monotherapy. The x-axis represents months from 0 to 40, and the y-axis represents the proportion surviving from 0.0 to 1.0. A table below the graph shows the number of patients at risk at various time points for both treatment groups.*
FDA Label Image

1 (Image 3)

1 (Image 3)
Packaging label for Topotecan Hydrochloride 4 mg/vial injection, powder, lyophilized for solution, indicated for intravenous use. The label shows it is a single-dose vial distributed by Actavis Pharma, Inc., including caution as a cytotoxic agent. Storage and handling instructions, reconstitution requirements, and manufacturing details by Sindan Pharma SRL are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.